Novavax NVAX recorded a loss of 19 cents per share in the third quarter of 2026, narrower than the Zacks Consensus Estimate ...

Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the third quarter ended ...

Novavax (NASDAQ:NVAX) raised its 2026 revenue framework after partner Sanofi began a late-stage trial of a combination ...

Sanofi milestones lifted revenue guidance to $400M, but profitability timing now depends on partner execution.

Gaithersburg-based Novavax reported a sharply narrower third-quarter loss, secured a $125 million milestone payment and outlined plans to extend its... Read More ...

In vitro studies, undertaken by two leading microbiology centers, confirm RHB-204's killing capability on Mycobacterium avium ...

Nearly $11 million grant supports study of gut bacteria St. Louis American staff Antibiotics can treat an infection while also wiping out helpful gut bacteria, allowing harmful bacteria to multiply.

Last time, I talked about how we live by exchanging microorganisms every day. This time, using the word 'boundary' as a clue, ...

A case report describes arginine vasopressin deficiency that emerged only after glucocorticoid therapy unmasked pembrolizumab ...

WVU Medicine St. Joseph’s Hospital earned national recognition for low C. diff infection rates after reporting zero ...

Friendly You can feel well while a stool PCR still detects norovirus RNA. Your symptoms, job, household contacts, and local ...

MELBOURNE, Australia, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore is presenting virtually at the ...